ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)
Clinical trial NCT05041972 · WITHDRAWN
Trial details
- NCT number
- NCT05041972
- Sponsor
- Ambrx, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2022-04-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.